Bacterial Infections

Infectious Disease·MeSH: Bacterial Infections

14 drugs in development·11 companies·4 clinical trials

Drug Pipeline by Phase

Approved(6)

Drug	Company
azithromycin	GT Biopharma, Inc. (GTBP)
clarithromycin	SUNSET ISLAND GROUP (SUN)
compound honeysuckle granules	Fuss Brands Corp. (FBDS)
metronidazole in plastic container	Amneal Pharmaceuticals, Inc. (AMRX)
tobramycin	Amneal Pharmaceuticals, Inc. (AMRX)
Zerbaxa	Merck & Co., Inc. (MRK)

Phase 3(1)

Drug	Company
nuzyra	Paratek Pharmaceuticals, Inc. (PRTK)

Phase 2(3)

Drug	Company
oritavancin	TG THERAPEUTICS, INC. (TGTX)
spr206	Spero Therapeutics, Inc. (SPRO)
vabomere	MELINTA THERAPEUTICS, INC. /NEW/ (MLNT)

Phase 1(3)

Drug	Company
c-scape	Achaogen, Inc. (AKAO)
omadacycline	Paratek Pharmaceuticals, Inc. (PRTK)
omadacycline injection [nuzyra]	Paratek Pharmaceuticals, Inc. (PRTK)

Preclinical(1)

Drug	Company
tellurium based compounds	Qrons Inc. (QRON)

BioSniper tracks 14 drugs in development for Bacterial Infections across 11 companies.

There are 4 clinical trials targeting Bacterial Infections tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.